貝康醫療－Ｂ (2170.HK)

2.010 +0.010 (+0.50%) 收市：03:59PM HKT

貝康醫療－Ｂ

Building A3 BioBay
Unit 101 No. 218 Xinghu Street Suzhou Industrial Park
Suzhou
China

https://www.basecare.cn

版塊: Healthcare
行業: Medical Devices
全職員工: 586

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Bo Liang Ph.D.	Chairman of the Board & GM	3.35M	無	1981
Mr. Maoshe Rui	Chief Operating Officer	337.06k	無	1989
Mr. Lingyin Kong	CTO & Executive Director	975.92k	無	1981
Ms. Ying Yang	Chief Quality Officer & Executive Director	626.75k	無	1982
Mr. Lejun Yin	CFO & Joint Company Secretary	無	無	1986
Mr. Ming Fai Chung C.P.A.	Joint Company Secretary	無	無	1979

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People's Republic of China and Australia. The company offers genetic test kit products, which include pre-implantation genetic test kits, such as PGT-A to detect aneuploidy; PGT-M to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage. It also offers liquid nitrogen storage dewar, Cryopreservation system, and sperm quality analyzer; universal kits for sequencing effects; sample preservation solution; and nucleic acid purification and DNA extraction kits. The company also engages in the research, development, manufacture, and sale of testing kits, testing devices, and instruments. In addition, it provides marketing services; and engages in the research and development of software for testing devices and instruments. The company serves hospitals and reproductive clinics. Suzhou Basecare Medical Corporation Limited was incorporated in 2010 and is headquartered in Suzhou, China.

公司管治

截至 無 止，貝康醫療－Ｂ 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。